Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 505.19%72.9M | 445.19%66.39M | 563.65%4.62M | -38.20%3.3M | 77.13%-1.41M | 807.76%12.05M | 221.01%12.18M | -90.79%696K | 42.16%5.34M | -8,107.79%-6.17M |
| Net profit before non-cash adjustment | -1,486.68%-57.15M | -12,559.23%-55.32M | -48.55%1.19M | -529.85%-3.74M | 46.11%732K | 157.66%4.12M | 123.34%444K | 255.64%2.31M | 130.57%871K | 154.75%501K |
| Total adjustment of non-cash items | 2,500.07%69.81M | 5,533.55%70.19M | -76.32%139K | 21.67%657K | -477.56%-1.18M | -29.86%2.69M | 11.35%1.25M | -17.56%587K | -45.01%540K | -69.26%312K |
| -Depreciation and amortization | -5.47%1.49M | -1.88%366K | -5.51%377K | -7.50%370K | -6.77%372K | -16.21%1.57M | -24.49%373K | -15.29%399K | -12.47%400K | -11.92%399K |
| -Reversal of impairment losses recognized in profit and loss | 17,148.35%68.13M | 10,429.26%69.81M | ---15K | ---15K | -514.93%-1.65M | -74.22%395K | 3.92%663K | --0 | --0 | -165.69%-268K |
| -Disposal profit | --117K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Net exchange gains and losses | ---- | ---- | ---- | ---- | ---- | --8K | ---- | ---- | ---- | ---- |
| -Remuneration paid in stock | --0 | ---- | ---- | ---- | ---- | -6.67%14K | ---- | ---- | ---- | ---- |
| -Other non-cash items | -88.79%79K | -150.00%-98K | -218.62%-223K | 115.71%302K | -45.86%98K | 79.85%705K | 566.67%196K | 21.29%188K | 12.00%140K | 17.53%181K |
| Changes in working capital | 1,049.50%60.23M | 391.21%51.52M | 250.00%3.29M | 62.62%6.39M | 86.19%-964K | 12.79%5.24M | 213.01%10.49M | -126.37%-2.2M | -30.15%3.93M | -30,243.48%-6.98M |
| -Change in receivables | 1,337.99%190.34M | 798.72%199.85M | 9.15%-43.23M | 46.77%22.76M | 298.21%10.97M | -167.31%-15.38M | 12.33%22.24M | -589.61%-47.58M | 3.43%15.5M | -9.69%-5.53M |
| -Change in payables | -985.58%-131.62M | -1,056.92%-138.28M | -15.95%39.19M | -62.09%-22.06M | -68.90%-10.48M | 235.28%14.86M | 52.57%-11.95M | 194.11%46.63M | -61.45%-13.61M | -191.43%-6.21M |
| -Changes in other current assets | -73.63%1.52M | -5,053.20%-10.06M | 689.23%7.33M | 179.93%5.69M | -130.44%-1.45M | 179.78%5.75M | 105.23%203K | -98.41%-1.24M | 316.74%2.03M | 369.38%4.76M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | 25.05%-748K | 13.10%-345K | 55.47%-110K | 27.65%-123K | 7.61%-170K | -998K | -169.28%-397K | -20.49%-247K | 7.61%-170K | 0.00%-184K |
| Interest received (cash flow from operating activities) | ||||||||||
| Tax refund paid | -11.65%-1.52M | -18.24%-512K | -17.33%-325K | -77.57%-467K | 43.88%-220K | 38.73%-1.37M | 71.40%-433K | 12.06%-277K | -87.86%-263K | -51.35%-392K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 629.41%70.63M | 477.51%65.54M | 2,332.56%4.18M | -44.77%2.71M | 73.30%-1.8M | 1,174.69%9.68M | 203.12%11.35M | -97.56%172K | 42.96%4.91M | -1,742.08%-6.74M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | -42.02%-338K | -4,800.00%-49K | 36.36%-35K | -2,212.50%-185K | 60.34%-69K | 79.16%-238K | 99.75%-1K | 84.55%-55K | 97.72%-8K | -370.27%-174K |
| Net intangibles purchase and sale | ---9K | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Advance cash and loans provided to other parties | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Interest received (cash flow from investment activities) | 159.30%669K | 166.87%443K | 464.41%333K | -696.67%-179K | 2,300.00%72K | -46.69%258K | -51.88%166K | 18.00%59K | -49.15%30K | -90.00%3K |
| Net changes in other investments | 10,524.68%24.97M | ---- | ---- | ---- | ---- | -57.89%235K | ---- | ---- | ---- | ---- |
| Investing cash flow | 9,817.65%25.29M | 6,240.50%25.36M | 7,125.00%289K | -1,754.55%-364K | 101.75%3K | 355.00%255K | -20.79%400K | 101.31%4K | 107.53%22K | -2,342.86%-171K |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | -1.26%-3.71M | 84.27%-931K | -122.73%-928K | -1.09%-925K | -1.32%-923K | 0.44%-3.66M | -554.65%-5.92M | 573.67%4.08M | 2.35%-915K | 6.47%-911K |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Cash dividends paid | ---17M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest paid (cash flow from financing activities) | ---- | ---- | ---- | ---- | ---- | 12.93%-660K | ---- | ---- | ---- | ---- |
| Net other fund-raising expenses | ---- | ---- | -193.33%-440K | ---- | ---- | ---- | ---- | ---150K | ---- | ---- |
| Financing cash flow | -465.61%-20.71M | -189.74%-17.48M | -134.78%-1.37M | -44.00%-936K | -1.32%-923K | 16.47%-3.66M | -263.21%-6.03M | 556.26%3.93M | 26.64%-650K | 6.47%-911K |
| Net cash flow | ||||||||||
| Beginning cash position | 52.87%18.15M | 60.39%19.94M | 102.26%16.84M | 281.15%15.43M | 52.87%18.15M | -31.20%11.87M | -48.26%12.43M | -54.16%8.33M | -74.56%4.05M | -31.20%11.87M |
| Current changes in cash | 1,098.22%75.21M | 1,184.65%73.42M | -24.43%3.11M | -67.06%1.41M | 65.24%-2.72M | 216.59%6.28M | 146.99%5.72M | -30.01%4.11M | 89.84%4.28M | -480.85%-7.82M |
| End cash Position | 414.41%93.36M | 414.41%93.36M | 60.39%19.94M | 102.26%16.84M | 281.15%15.43M | 52.87%18.15M | 52.87%18.15M | -48.26%12.43M | -54.16%8.33M | -74.56%4.05M |
| Free cash flow | 644.12%70.28M | 477.13%65.49M | 3,438.46%4.14M | -48.46%2.52M | 72.98%-1.87M | 561.86%9.45M | 199.49%11.35M | -98.25%117K | 58.99%4.9M | -1,616.13%-6.92M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.